18:1溶血磷脂酰胆碱促进周围神经损伤后神经病理性疼痛
该研究在小鼠脊神经结扎模型中观察到LPC(18:1)在血清、背根神经节和脑脊液中显著升高,外源性给予LPC(18:1)可诱发痛觉过敏并激活背根神经节PKC、ERK及脊髓胶质细胞,其效应由GPR132介导,提示LPC(18:1)可作为神经病理性疼痛的潜在生物标志物和治疗靶点。
要点
- 神经损伤后血清、背根神经节和脑脊液中LPC(18:1)水平显著升高。
- LPC(18:1)通过GPR132激活PKC、ERK及脊髓胶质细胞参与痛觉过敏。
- LPC(18:1)有望成为神经病理性疼痛的生物标志物和治疗靶点。
核心结论
- LPC(18:1)可能作为神经病理性疼痛的潜在生物标志物和治疗靶点。
研究设计与样本
- 采用小鼠脊神经结扎模型,检测血清、背根神经节、脊髓和脑脊液中LPC(18:1)水平。
- 采用von Frey和Hargreaves方法评估痛觉行为,并进行炎症通路和氧化应激的分子分析。
主要发现
- 神经损伤后血清、背根神经节和脑脊液中LPC(18:1)水平显著升高。
- 给予LPC(18:1)可诱导痛觉反应增强,并激活背根神经节中PKC和ERK炎症通路及脊髓胶质细胞。
- 氧化应激参与LPC(18:1)的生成,其效应由GPR132介导。
临床怎么用
- LPC(18:1)及其下游GPR132通路可作为神经病理性疼痛机制研究和干预的潜在方向。
局限性
- 研究基于小鼠脊神经结扎模型,结论外推至临床患者需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neuropathic pain is a maladaptive and chronic condition with limited effective treatments. Although recent studies have suggested that certain lipid metabolites, like lysophosphatidylcholine (LPC), may contribute to chronic pain, their specific roles and mechanisms remain unclear. OBJECTIVE: This study investigated the role and mechanism of LPC(18:1), a lipid subtype, in neuropathic pain caused by nerve injury. METHODS: Using a mouse model of spinal nerve ligation, LPC(18:1) levels were measured in serum, dorsal root ganglion (DRG), spinal cord (SC) and cerebrospinal fluid (CSF). Nociception was assessed using von Frey and Hargreaves' methods, while molecular analyses explored inflammatory pathways and oxidative stress. RESULTS: LPC(18:1) levels significantly increased in the serum, DRG and CSF after nerve injury. Administration of LPC(18:1) induced heightened pain responses and activated inflammatory pathways, including protein kinase C (PKC) and extracellular regulated protein kinase (ERK) in the DRG, as well as glial cells in the SC. The findings suggested that oxidative stress played a role in LPC(18:1) production, and its effects were mediated by G protein-coupled receptor 132 (GPR132). CONCLUSION: LPC(18:1) may serve as a potential biomarker and therapeutic target for managing neuropathic pain.
引用
- Ren J, Yu L, Lin J, et al. Elevated 18:1 lysophosphatidylcholine contributes to neuropathic pain in peripheral nerve injury. Reg Anesth Pain Med. 2026. PMID: 40016127. doi:10.1136/rapm-2024-106195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。